The selection of patients with ovarian epithelial carcinoma for fertility-preserving surgery should be particularly cautious. Existing studies, with the exception of case reports, have mostly investigated stage I ovarian epithelial carcinoma for fertility-preserving surgery. Among the most recent guidelines, the US NCCN guidelines represent the highest level of oncology specialties, and the 2014 NCCN guidelines recommend fertility-preserving surgery for ovarian epithelial carcinoma in patients with unilateral, stage IA or stage IC with unlimited differentiation. The UK NICE guideline is consistent with its choice. The European Society of Medical Oncology (ESMO) has some minor differences, in that ESMO does not recommend fertility preserving surgery for hypofractionated or clear cell carcinoma. 2014, the latest guidelines for the management of gynecologic malignancies in China suggest that fertility preserving surgery for ovarian epithelial carcinoma is only applicable to patients with stage IA and high differentiation. The guidelines in China are more cautious because of the varying medical standards in China, with 90% of the hospitals at level II and below.